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Abstract
Adenovirus protein VII is the major protein component of the viral nucleoprotein core. It is a nonspecific DNA-binding protein that condenses
viral DNA inside the capsid. Protein VII remains associated with viral chromatin throughout early phase, indicating its continuing role during
infection. Here we characterize the release of protein VII from infectious genomes during a time period that corresponds to the late phase of
infection. Interestingly, the early viral transactivator E1A, but not other early gene products, is responsible for releasing protein VII by a
mechanism that requires ongoing transcription but not viral DNA replication. Moreover transcription per se, in the absence of E1A, is also
sufficient to trigger release. Accordingly, a recombinant genome containing only non-coding “stuffer” DNA is unable to support release of protein
VII. Our data support a model in which early gene transcription results in a change in the structure of the viral chromatin.
© 2007 Elsevier Inc. All rights reserved.Keywords: Adenovirus; Transcription; Chromatin; Gene therapy; Protein VIIIntroduction
Transcriptional regulation during virus infection ensures the
proper timing and amount of gene expression. In adenovirus
infection, early phase is controlled in large part by the
transcriptional activator E1A. Transcription of the early genes
leads to production of viral regulatory and replicative functions
that are required for DNA replication to commence (Shenk,
2001). Likewise viral DNA replication is a necessary precursor
to the initiation of late phase transcription (the early-to-late
switch) and the associated production of viral structural proteins
(Flint, 1986; Iftode and Flint, 2004; Thomas and Mathews,
1980).
The physical state of adenovirus chromatin is likely
important in the regulation of transcription and DNA replication
during infection. The earliest transcriptional events upon
introduction of viral DNA into the nucleus are governed by
the interplay between cellular factors and the viral chromatin.
Within the virion, the viral nucleoprotein core is composed of
highly basic proteins μ (mu), protein Vand protein VII, and also⁎ Corresponding author. Fax: +1 434 982 1071.
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doi:10.1016/j.virol.2007.08.012protein IVa2 and the 55 kDa terminal protein (Amin et al., 1977;
Brown et al., 1975; Hosokawa and Sung, 1976; Maizel et al.,
1968; Prage and Pettersson, 1971; Rekosh et al., 1977; Russell
et al., 1968; Weber et al., 1983). Of these, protein VII is the most
abundant and is primarily responsible for condensation of the
viral DNA inside the virion. Upon infection protein VII enters
the nucleus along with viral DNA and remains associated with it
throughout early phase and the beginning of DNA replication
(Chatterjee et al., 1986; Greber et al., 1996; Haruki et al., 2003;
Johnson et al., 2004; Xue et al., 2005). It is capable of highly
efficient DNA condensation in vitro and in vivo and can
efficiently repress cellular transcription in vivo when introduced
by microinjection (Black and Center, 1979; Johnson et al.,
2004). The association of protein VII with viral DNA during
infection suggests an ongoing regulatory requirement for this
protein. However it is not known what precise roles protein VII
might play in mechanisms of transcriptional repression or
transcriptional activation of the viral genome.
Regulation of the protein VII–DNA complex by host factors
during infection is important in the regulation of the viral
transcriptional program. The host protein SET/template activat-
ing factor-Iβ (TAF-Iβ) can associate with protein VII in vitro
and in vivo (Haruki et al., 2003, 2006; Xue et al., 2005). SET/
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efficiently stimulate transcription and DNA replication from
adenovirus nucleoprotein core preparations (Kawase et al.,
1996; Okuwaki and Nagata, 1998). RNAi knockdown of SET/
TAF-Iβ resulted in reduced expression of the E1A and E2
mRNAs during infection, indicating a role for this protein in
transcription from viral templates (Haruki et al., 2006). The
cellular protein pp32 can also associate with protein VII in
vitro, possesses nucleosome assembly activity and associates
with adenovirus chromatin during infection (Haruki et al., 2006;
Xue et al., 2005). SET/TAF-Iβ and pp32 are both components
of the cellular SET and INHAT complexes (Beresford et al.,
2001; Brennan et al., 2000; Fan et al., 2002; 2003a,b; Seo et al.,
2002, 2001), suggesting that these complexes may have a role in
viral transcriptional regulation. However RNAi knockdown of
pp32 did not affect viral early transcription in a recent study
(Haruki et al., 2006).
Previously we reported that protein VII localizes as nuclear
dots within 1–2 h of infection of HeLa cells and that these dots
remain intact through the first 10–12 h of infection (Xue et al.,
2005). During this time period protein VII associates with viral
DNA as shown by chromatin immunoprecipitation (ChIP)
assay, indicating that the dots represent individual infectious
genomes (Haruki et al., 2003; Johnson et al., 2004; Xue et al.,
2005). Furthermore, the number of protein VII dots in the
nucleus corresponds to the multiplicity of infection (MOI) and
protein VII nuclear dots co-localize with SET/TAF1β, which
has been demonstrated to regulate viral transcription (Haruki et
al., 2006; Xue et al., 2005). Since protein VII associates with
viral DNA throughout early phase we concluded that it has an
ongoing role in establishing and/or regulating viral chromatin
structure during early phase transcription. Interestingly, protein
VII dots disappear from the nucleus between 10 and 16 h post-
infection. Moreover α-amanitin, a potent inhibitor of transcrip-
tion, prevents disappearance of the dots, suggesting that the
transcriptional state of the viral template is coupled to protein
VII function. In contrast, inhibitors of viral DNA replication
such as cytosine arabinoside (AraC) and hydroxyurea (HU) do
not prevent loss of the protein VII dots (Xue et al., 2005). These
data suggest that a transcriptional mechanism is responsible for
loss of protein VII from the dot structures and that an
uncharacterized mode of regulation is at play here. In this
report we characterize the mechanism by which association of
protein VII with nuclear dot structures is disrupted between 10
and 16 h post-infection. Our results point to a novel
transcriptional regulatory mechanism that serves the adenovirus
gene expression program.
Results
Timed loss of protein VII from nuclear dots
The loss of protein VII nuclear staining between 10 and 16 h
post-infection implies a regulatory step at this stage of infection,
during which DNA replication and late phase are proceeding.
Therefore we investigated the mechanism of loss of protein VII
dots during infection. Fig. 1 shows the presence and locationof protein VII during the period 4–12 h post-infection. HeLa
cells were infected with phenotypically wild-type dl309. At
various times after infection the cells were fixed and stained
with an anti-protein VII polyclonal antibody. The infections
were performed in the absence or presence of HU to block viral
DNA replication. Since DNA replication is required for
initiation of late phase transcription (Thomas and Mathews,
1980), treatment with HU prevents new synthesis of protein
VII, a late gene product of the L2 mRNA. Therefore all protein
VII staining in cells treated with HU represented material that
entered along with the infecting virus. Fig. 1 shows that nuclear
protein VII staining remained strong through 8–10 h post-
infection. By 10 h the protein VII dots became somewhat fewer
in number, and at 12 h post-infection the dots were mostly
absent; those that remained were weak in intensity. Fig. 3
shows that by 16 h post-infection the dots disappeared entirely
(dl309+AraC panel). These data demonstrate that there is a
switch in protein VII regulation that occurs around 10–12 h
post-infection.
Release of protein VII
Interestingly, for cells infected for 12 h or longer we noticed
the appearance of faint but reproducible diffuse nuclear staining
for protein VII that correlated with the decrease in intensity of
the dots, suggesting that protein VII was released from the dot
structures but was retained in the nucleus. To see this diffuse
staining more clearly, cells were infected at a higher MOI to
provide additional material for observation and analyzed as
before. Importantly, cells were treated with AraC starting at
1 hour post-infection to block DNA synthesis and prevent
production of new protein VII. Fig. 2A shows that, concomitant
with loss of the dots, protein VII redistributed generally within
the nucleus. For clarity, nuclear DAPI staining is not shown in
Fig. 2A. Western blot analysis confirmed that the bulk of protein
VII was still present at the 12 hour time point, indicating that
released protein VII remains in the cell. Since we previously
demonstrated that virtually all cell-associated protein VII is
found in the nucleus (Johnson et al., 2004) this indicates that the
majority of the released protein VII is nuclear and is not
degraded. In addition, treatment of cells with AraC completely
blocked the synthesis of new pre-protein VII, demonstrating
that the appearance of protein VII as general nuclear staining
shown here was not due to new synthesis (Fig. 2B). Finally,
prior treatment with α-amanitin completely prevented the
appearance of the diffuse nuclear staining, demonstrating that
active transcription is required for this redistribution (data not
shown). These data indicate that loss of protein VII dots is due
to release of the protein from viral chromatin. Consistent with
this, it has been reported that there is a decrease in protein VII–
DNA association during this time period as measured by ChIP
(Haruki et al., 2003).
E1A protein triggers release of protein VII
As reported earlier, the ability of α-amanitin to prevent loss
of protein VII dots from the nucleus indicated that there is an
413J. Chen et al. / Virology 369 (2007) 411–422active, transcription-dependent process that mediates this loss.
Three possible mechanisms of protein VII loss that rely on
transcription are: (1) production of E1A protein and directaction of E1A on protein VII or the viral chromatin, (2)
production and action of an E1A-induced early viral gene
product(s) such as E1B, E2 or E4, and (3) transcriptional
elongation by RNA polymerase II, or a related process, which
could directly displace protein VII from the chromatin.
First, to investigate the role of E1A, HeLa cells were
infected with mutant dl312, which contains a large in-frame
deletion of the E1A gene and fails to produce any of the E1A
gene products (Jones and Shenk, 1979). For comparison, cells
were also infected with wild-type dl309 in the presence of
either AraC or α-amanitin to block DNA replication or tran-
scription, respectively. Cells were infected at an MOI of 5–15
and stained for protein VII at 4, 12 and 16 h post-infection. As
shown in Fig. 3, dl309 infected cells contained intensely
stained protein VII dots at 4 h post-infection. By 12 h post-
infection the dots exhibited less intense staining and were fewer
in number, and at 16 h post-infection they were completely
absent (top panel). In the absence of AraC, by 16 h post-
infection some cells showed intense general protein VII nuclear
staining, indicative of new protein VII synthesis (top panel,
arrows). Cells treated with AraC behaved identically to
untreated cells with respect to loss of the dots, thus demon-
strating that ongoing viral DNA synthesis is not required to
trigger this loss. In addition, AraC completely blocked new
protein VII synthesis due to the requirement of DNA repli-
cation for late gene expression. As reported previously, cells
treated with α-amanitin retained their protein VII dots,
indicating that transcription is required for disappearance of
the dots. Interestingly, the dl312 mutant also contained protein
VII dots throughout the entire time course of infection,
suggesting that E1A protein is required for loss of the dots.
To test the involvement of additional early gene products,
mutants with defects in the E1B, E2, E3 and E4 genes were
examined. As shown in Fig. 4 all early gene mutants with the
exception of dl312 exhibited a wild-type phenotype: each
mutant exhibited loss of protein VII dots by 16 h post-
infection.
It seemed likely that the defect in dl312 was due to the lack
of production of E1A protein, but the possibility existed that an
unanticipated alteration in dl312 chromatin structure prevented
proper regulation of protein VII. To distinguish between these
possibilities, dl312 was used to infect human 293 cells, which
produce the viral E1A and E1B proteins endogenously. As
shown in Fig. 5A, dl312 infection of 293 cells resulted in
complete disappearance of protein VII dots. These data
demonstrate that the dl312 chromatin is fully capable of
supporting protein VII regulation and that the effect on protein
VII regulation is in trans.Fig. 1. Time course of protein VII localization. HeLa cells were plated on glass
cover slips and infected for the indicated times with wild-type dl309. The cells
were fixed by cold methanol dehydration and probed with rabbit polyclonal anti-
protein VII antibody. For visualization, the cells were incubated with goat anti-
rabbit Alexa Fluor 594 secondary antibody conjugate. Prior to mounting, the
cells were counterstained with DAPI. For this and all subsequent figures, the
CCD camera sensitivity was kept constant for the multiple images presented in
the composite figures to allow accurate comparison. Protein VII is shown in
white. DAPI is shown in gray. Mock, uninfected control; HU, hydroxyurea.
Fig. 2. (A) Nuclear release of protein VII. HeLa cells were infected with dl309 at an MOI of 10 (low) or 50 (high) for the indicated times, in the presence of AraC. The
cells were fixed by cold methanol dehydration and probed with rabbit polyclonal anti-protein VII antibody. For visualization, the cells were incubated with goat anti-
rabbit Alexa Fluor 594 secondary antibody conjugate. Mock, uninfected control. (B) Western blot analysis of protein VII. Cells were infected for the indicated times in
the presence or absence of AraC and analyzed by Western blot using a polyclonal anti-VII antibody. Pre-VII, precursor to protein VII.
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only by an internal 46 amino acid domain found in E1A289 that
confers a potent transcriptional activation function (Berk,
1986). To determine which E1A protein is responsible for
triggering disappearance of protein VII dots, cells were infected
with pm975, which produces only E1A289, or dl520, which
synthesizes only E1A243. As shown in Fig. 5B dl520 failed to
cause dot disappearance whereas pm975 had a wild-type
phenotype. Since E1A289 is the major viral transcriptional
activator this result indicates that disappearance of protein VII
dots correlates with the ability of E1A289 to activate viral early
transcription. Interestingly, it should be noted that, prior to 10–
12 h post-infection, a period during which E1A289 is active and
early viral transcription is ongoing (Shenk, 2001; Xue et al.,
2005), no loss of protein VII from the dot structures was
observed. This indicates a specific change in the regulation of
protein VII after 10 h post-infection that is due to the action of
E1A.
As a final test to rule out the involvement of any additional
adenovirus gene products in loss of protein VII dots duringinfection, a recombinant “helper-dependent” (HD) adenovirus
was employed that encodes no adenovirus proteins. Virus gAd.
HSU/GFP contains approximately 28 kb of non-coding human
stuffer DNA (Sandig et al., 2000) flanked by the adenovirus
inverted terminal repeats from the extreme left and right ends of
the viral genome. Embedded within the stuffer DNA is the gene
for green fluorescent protein (GFP), under control of the CMV
promoter. To produce gAd.HSU/GFP, cells were co-transfected
with helper-dependent and helper adenovirus DNA, which
encoded the necessary replication functions and structural
components. During propagation, the helper sequences were
discarded by way of a cre-lox mechanism that specifically
excised the adenovirus packaging sequences from the helper
genome, rendering it incapable of being packaged into virions
(Chen et al., 1996; Parks et al., 1996). Therefore the gAd.
HSU/GFP virus is constituted with all adenovirus capsid and
nucleocapsid core proteins, including protein VII, however it is
unable to produce viral proteins de novo. Fig. 6A (topmost
panel) shows the results of infection of gAd.HSU/GFP in HeLa
cells. Protein VII dots remained even after 18 h of infection.
Fig. 3. E1A is required for loss of dots. HeLa cells were infected for the indicated times with dl309 or E1Amutant dl312, in the presence or absence of AraC (25 μg/ml)
or α-amanitin (20 μg/ml). The cells were fixed and stained for protein VII and cellular DNA as described in Fig. 1 andMaterials and methods. Arrows indicate cells that
are synthesizing new protein VII. Mock, uninfected control.
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products proper regulation of protein VII is disrupted. In some
experiments, a minor reduction in the intensity of staining was
observed at the 18 hour time point with gAd.HSU/GFP (see
also Fig. 8, topmost panel). This reduction is due to the pre-
sence of the CMV promoter and GFP gene sequences and will
be addressed below.
Again, the ability of E1A proteins to act in trans was tested.
gAd.HSU/GFP was used to infect 293 cells (Fig. 6B). Also,
gAd.HSU/GFP was co-infected along with wild-type dl309 in
HeLa cells (Fig. 6A, bottommost panel). In both experiments
protein VII dots were lost by 18 h post-infection. Concomitant
with the loss of protein VII dots, an approximately three-fold
increase in GFP expression was observed in cells co-infected
with dl309 (data not shown). This activation of the CMV-driven
GFP gene was due to the action of E1A, which has been shown
to activate the CMV promoter (Cockett et al., 1991; Gorman etal., 1989; Olive et al., 1990). Since the experiments presented in
Fig. 4 eliminated early genes E1B, E2, E3 and E4 in causing
loss of protein VII dots we again conclude that loss of protein
VII staining in gAD.HSU/GFP infected cells was due to the
action of E1A.
Transcription per se is sufficient to release protein VII
Two mechanisms could account for the role of E1A in
protein VII regulation. First, E1A could interact with protein
VII or other components of the viral chromatin and thereby
directly trigger loss of protein VII from the chromatin.
Alternatively, transcriptional activation by E1A could cause
displacement of protein VII from the chromatin due to
transcriptional elongation by RNA polymerase II or a related
process such as chromatin remodeling. To investigate this we
took advantage of a second helper-dependent vector that is
Fig. 4. Effect of early gene mutations on protein VII localization. HeLa cells were infected for the indicated times with viruses that fail to express E1B 55k protein
(dl338), E1B 19k protein (dl337), E2B DNA polymerase (ts149), E2A 72k DNA-binding protein (ts125), E2B pre-terminal protein pTP (Ad5dl300ΔpTP), double
mutant E2B pTP plus E3 (Ad5dl327ΔpTP), E4 (dl366) and E1A (dl312). For the ts125 and ts149 experiments, cells were maintained at 40 °C for the entire time course
to inactivate the 72k DNA-binding protein and DNA polymerase, respectively. The cells were fixed and stained for protein VII and cellular DNA as described in Fig. 1
and Materials and methods.
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2000) contains 28 kb of non-coding human sequences (identical
to those in gAd.HSU/GFP) flanked by the adenoviral left and
right-end inverted terminal repeats. If E1A is sufficient directly
to displace protein VII, it would be expected to do so in the
context of gAd.HSU chromatin. However, if the presence of
gene sequences is required for E1A to act, the gAd.HSU
chromatin would be resistant to the action of E1A. As shown in
Fig. 7 (topmost panel) there was no loss of protein VII dots
when gAd.HSU was used to infect HeLa cells over an 18 hour
time course. This result was similar to that shown in Fig. 6A for
gAd.HSU/GFP. Interestingly, when gAd.HSU was co-infected
along with dl309 (Fig. 7A), about 50% of protein VII dots
remained (compare 4 hour with 18 hour time point). Since loss
of dots from the co-infecting dl309 genomes is expected in this
experiment, this result suggests that there was no loss from thegAd.HSU genomes, thus resulting in an overall 50% loss of the
dots. To confirm this behavior of gAd.HSU, it was used to infect
293 cells expressing E1A (Fig. 7B). No loss of the dots was
observed. This is in contrast to the results obtained with gAd.
HSU/GFP presented in Fig. 6, where co-infection with dl309 or
infection of 293 cells resulted in complete loss of the dots. Since
the only difference between gAd.HSU/GFP and gAd.HSU is
the CMV promoter and GFP gene sequences in gAd.HSU/GFP,
we conclude that the presence of active gene sequences is
required for release of protein VII from the viral chromatin.
Next we tested the hypothesis that transcription itself, in the
absence of E1A, is sufficient to trigger loss of the protein VII
dots. The CMV promoter contains binding sites for NFκB and
CREB/ATF, which can be regulated by PMA and forskolin,
respectively (Meier and Stinski, 1996). Accordingly, HeLa cells
were infected with gAd.HSU/GFP and then treated with a
Fig. 5. E1A289 but not E1A243 triggers loss of protein VII dots. (A) 293 cells
were infected for the indicated times with mutant dl312. (B) HeLa cells were
infected with mutant viruses that express either E1A289 (pm975) or E1A243
(dl520) for the indicated times. The cells were fixed and stained for protein VII
and cellular DNA as described in Fig. 1 and Materials and methods.
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the GFP gene. As shown in Fig. 8B, in the absence of PMA and
forskolin a relatively low amount of GFP protein could be
detected by fluorescence microscopy. When the cells were
stained for protein VII (Fig. 8A, topmost panel) dots were
visible at 4 and 18 h post-infection, although there was some
weakening of their intensity by 18 h. This indicates that the
presence of protein VII is compatible with a low level of
transcription. Upon induction with PMA and forskolin, a
significant increase in GFP expression was observed (Fig. 8B).
Interestingly, this resulted in complete loss of protein VII dots
after 18 h of incubation. As a control, cells were also infected
with gAd.HSU and treated identically with the combination of
PMA and forskolin. No loss of protein VII dots was observed,
again demonstrating that gene sequences are required for loss of
the dots to take place. This control also demonstrated that
treatment of cells with PMA and forskolin did not lead to loss ofprotein VII dots by way of a transcription-independent
mechanism. We conclude that a high level of transcription per
se is sufficient to displace protein VII from the viral chromatin
in the absence of E1A.
Discussion
This work addresses several questions regarding the
regulation of viral chromatin and the handling of viral templates
during infection. First, the regulation of early phase transcrip-
tion, which has been well studied, must now be considered in
the context of chromatin constituted with protein VII. The
presence of protein VII throughout early phase and its abrupt
exit during the beginning of late phase argue for important
regulatory events during both stages. Since protein VII is a
powerful transcriptional repressor and is associated with viral
DNA throughout early phase (Haruki et al., 2003; Johnson et
al., 2004; Xue et al., 2005), a reasonable model is that it acts to
dampen transcription during early phase. The reasons for this in
terms of viral biology are not known, but it may be that an
inappropriately high level of early protein synthesis is
mechanistically counterproductive to viral replication. Alter-
natively high protein levels could stimulate the host immune
response in a way that is detrimental to virus replication. Simian
Virus 40 (SV40) prevents protein overexpression using a
different mechanism, by the production of microRNAs that
dampen expression of large T antigen, leading to lowered
sensitivity to CTL killing (Sullivan et al., 2005). Yet another
possibility is that overactive early transcription could physically
prevent the initiation of DNA synthesis, which must originate
from a template that has already produced early transcripts. If
such a template were associated with a highly dense array of
RNA polymerase II and associated factors, it might not be
capable of initiating DNA synthesis.
We found that transcription intrinsically is sufficient to effect
release of protein VII. Release could be triggered by the passage
of elongating RNA polymerase or alternatively could be
mediated by transcription-associated functions such as host
chromatin remodeling complexes. As mentioned above, SET/
TAF-Iβ and pp32 have been implicated in early gene control
and are therefore potential candidates for carrying out this
function. However, these proteins associate with viral chroma-
tin as early as 4 h post-infection whereas the bulk of protein VII
is released much later (Haruki et al., 2003; Xue et al., 2005).
Therefore another step is likely required to effect release,
although SET/TAF-Iβ and/or pp32 may be involved. Recently,
evidence for an E1A-independent release of a population of
protein VII molecules was reported to occur within 4 h post-
infection (Spector, 2007). This release is proposed to occur very
early after the viral DNA enters the nucleus and may be carried
out by SET/TAF-Iβ. Perhaps this initial, E1A-independent
release of protein VII is involved in setting up the viral
chromatin for early transcription, and the late phase release we
have observed is for the purpose of sustaining or modifying it.
In line with our findings, several studies have observed
increases in early gene mRNAs during the time period of
protein VII release. Also in line with our results, chromatin
Fig. 6. Release of protein VII from a helper-dependent adenovirus vector that expresses GFP from the CMV promoter. (A) HeLa cells or (B) 293 cells were infected
with the indicated viruses. The amount of helper-dependent virus particles used in the experiments was determined as described in Materials and methods. The cells
were fixed and stained for protein VII and cellular DNA as described in Fig. 1 and Materials and methods.
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decreases over this same period of infection (Haruki et al.,
2003).
We found that release of protein VII occurs during a time
window after the completion of early phase. Interestingly, we
showed that this regulation does not require DNA replication or
the early-to-late switch: it was not prevented by inhibitors of
DNA replication or replication-defective mutants ts125 or ts149.
It has been demonstrated by many laboratories that the early
genes, which collectively span almost the entire viral genome,
are actively transcribed during the first 8–10 h of infection
(Shenk, 2001), yet there is no evidence for protein VII release in
our assay during this time period. This indicates that multiple
rounds of transcription through protein VII–DNA complexesfail to release the protein. This situation is similar to that of
transcriptionally active cellular chromatin. Typically histones
are not irreversibly displaced from coding sequences in an
extensive manner. Instead it has been proposed that components
of the elongation machinery actively replace H2A–H2B dimers
or entire nucleosomes as the elongating polymerase passes
through. In some cases however, histones are displaced from
active promoters or from entire coding regions (Workman,
2006). Also, a ChIP-on-chip study provided evidence for large-
scale release of histones from highly transcribed gene coding
regions (Lee et al., 2004). This situation may be similar to that
observed in this report, as follows. The gAd.HSU/GFP virus was
transcriptionally active at a low level in the absence of inducers
PMA and forskolin (Fig. 8B). Under these conditions protein VII
Fig. 7. Failure to release protein VII from a helper-dependent adenovirus vector containing only non-coding sequences. (A) HeLa cells or (B) 293 cells were infected
with the indicated viruses. For the co-infection experiment (bottom panel of A) the cells were treated with HU to prevent DNA replication. The cells were fixed and
stained for protein VII and cellular DNA as described in Fig. 1 and Materials and methods.
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time point, some diminishment in intensity of the protein VII
signal was observed in some experiments (Fig. 8A). This
suggests that a low level of transcription is much less efficient at
displacing protein VII than the high level seen when the cells
were treated with PMA and forskolin. Taken together our data
support a model in which early transcription is set at a low level
during infection, due to the presence of protein VII. At later
times there may be an E1A-dependent increase in transcription
of the input templates that forces protein VII release and alters
the viral chromatin. A variation of this mechanism is that E1A
could activate transcription and also trigger release of protein
VII by a concerted mechanism that allows transcription to
increase maximally. This would be consistent with our previous
finding that E1A and protein VII can associate in vitro (Johnson
et al., 2004). As mentioned above cellular mechanisms seem toexist for carrying out nucleosome displacement on highly active
cellular genes. Such mechanisms may be at work on adenovirus
chromatin as well.
Materials and methods
Cells and viruses
HeLa cells were grown as monolayers in Dulbecco's
modified Eagle medium (DMEM) supplemented with 10%
newborn calf serum (NCS), penicillin and streptomycin (all
from GIBCO). Where indicated, cells were treated with AraC
(25 μg/ml) or HU (10 mM). 293 cells were grown in the same
medium except fetal bovine serum was used. Adenovirus type 5
dl309 (Jones and Shenk, 1979) was propagated in HeLa cells to
produce virus stocks. E1A mutants dl312 (Jones and Shenk,
Fig. 8. Induction of transcription releases protein VII in the absence of E1A. HeLa cells were infected with the indicated viruses in the presence or absence of a
combination of PMA and forskolin. (A) The cells were fixed and stained for protein VII and cellular DNA as described in Fig. 1 and Materials and methods. (B) Prior
to fixing the cells were photographed using a fluorescence microscope. Mock-infected cells showed no background fluorescence (not shown).
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1984) were propagated in 293 cells. E1B mutants dl337 (Pilder
et al., 1984) and dl338 (Pilder et al., 1986) were gifts from D.
Ornelles. Pre-terminal protein (pTP) mutant Ad5dl300ΔpTP,
pTP-E3 double mutant Ad5dl327ΔpTP (Schaack et al., 2004)
and E2B mutant ts149 (Straus et al., 1975) were gifts from J.
Schaack. E4 mutant dl366 (Halbert et al., 1985) and E2A
mutant ts125 (Straus et al., 1975) were gifts from P. Hearing.
Helper-dependent adenoviral vectors were generated using a
Cre-loxP system obtained from Microbix (Chen et al., 1996;
Parks et al., 1996; Sandig et al., 2000). This consists of plasmid
pC4HSU, in which expression cassettes are cloned, Cre
recombinase-expressing 293Cre4 cells and helper virus H14,
which is an E1-deleted adenovirus containing loxP sitesflanking the packaging signal (Sandig et al., 2000). Plasmids
pC4HSU and pC4HSU/GFP were digested with Pme I,
transfected into 293Cre4 cells and helper H14 was added to
generate helper-dependent vectors gAd.HSU and gAd.HSU/
GFP, respectively. Details of the rescue and amplification
process are described elsewhere (Witting et al., submitted for
publication). The virus was purified by CsCl step gradient
centrifugation followed by CsCl isopycnic separation. The
helper-dependent adenovirus band was collected and dialyzed
against 10 mM Tris–HCl (pH 7.5), 1 mM MgCl2, 150 mM
NaCl and 10% glycerol. The level of contamination with helper
was determined by plaque assay and shown to be lower than
0.03%. For experiments using helper-dependent viruses, initial
titrations were performed assuming a particle to infectious unit
421J. Chen et al. / Virology 369 (2007) 411–422ratio of between 20:1 and 50:1 (Kreppel et al., 2002). Cells were
stained for protein VII and dots per nuclei were counted. An
amount of helper-dependent virus corresponding to 5–10 dots
per nucleus was used for subsequent experiments.
Immunofluorescence
HeLa cells were grown on 22- by 22-mm glass coverslips
(Fisher) for 24 h prior to infection. Cells were infected for 1 h as
previously described (Johnson et al., 2004). Cells were then
washed two times in PBS to remove unadsorbed virus followed
by incubation in DMEM plus 10% NCS at 37 °C. After
incubation the cells were washed with PBS and fixed with
100% methanol for 10 min at −20 °C followed by air drying.
Cell staining was performed essentially as described previously
(Ornelles and Shenk, 1991). Cells were rehydrated in PBS
supplemented with 1.5 mMMgCl2 (PBS+) three times for 5 min
followed by incubation in blocking buffer (25 mM Tris [pH
8.0], 137 mM NaCl, 3 mM KCl, 1.5 mM MgCl2, 2.5% bovine
serum albumin, 13 mM glycine, 0.05% Tween 20 and 20% goat
serum) for 1 h. Cells were then incubated in blocking buffer
containing affinity-purified anti-protein VII rabbit polyclonal
antibody for 100 min followed by washing four times in PBS+
supplemented with 0.1% Tween 20 for 10 min. Cells were then
incubated with goat anti-rabbit Alexa Fluor 594 (Invitrogen)
secondary antibody conjugate in blocking buffer for 45 min in
the dark, followed by washing four times in PBS+ supplemen-
ted with 0.1% Tween 20 for 10 min, and were then washed three
times in PBS+ for 5 min. Cells were then dipped briefly in H2O
and mounted on glass slides in Vectashield mounting media
with DAPI (Vector Laboratories, Inc.). All steps were at room
temperature unless otherwise noted. Slides were sealed with nail
polish and examined using a Nikon Eclipse E800 fluorescence
microscope and a Princeton Instruments charged-coupled-
device camera.
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